Log in
Pharmacology · Drugs and Prescriptions

Warfarin

Warfarinum

Warfarin is an indirect anticoagulant, a coumarin derivative. The drug inhibits blood coagulation by blocking vitamin K-dependent metabolic processes and is widely used for the prevention of thromboembolic complications.

Pharmacological groupAgents affecting the blood system (indirect anticoagulants).
MetabolismMicrosomal oxidation in the liver (cytochrome P-450 system, predominantly CYP2C9).
Dosage formTablets, 0.001–0.01 g.
Half-lifeFrom 30 to 60 hours (depending on the stereoisomer).
How to write a prescription
Rp.: Tab. Warfarini 0,0025
D.t.d. N 50
S. Внутрь по 1 таблетке 1 раз в сутки в одно и то же время под контролем МНО

Alternative entries: Tabulettas Warfarini 0.0025; Tab. Warfarini natrii 0.0025; Tab. Warfarini 0.005

Dosage form
Tab. 0.001–0.01 g
Administration
Orally 0.001–0.01 g
Group
Agents affecting the blood system
3 min readFor medical studentsUpdated 09/24/2026
Material prepared by WhiteCoat Pro editorial team based on platform study guidesReviewed by medical editor: Aulov A. A., general practitioner · 09/24/2026

Mechanism of action and metabolism

Warfarin is a racemic mixture of R- and S-isomers, with the S-isomer possessing 4–5 times greater anticoagulant activity. The drug undergoes intensive microsomal oxidation in the liver. A key role is played by the CYP2C9 isoenzyme, which metabolizes the S-isomer. Genetic polymorphism of this enzyme is the primary cause of interindividual differences in therapy sensitivity.

Drug interactions

Warfarin has a narrow therapeutic index, making it highly sensitive to interactions.

  1. Displacement from protein binding: Sulfonamides displace warfarin from binding to albumins (99% protein bound), which sharply increases the concentration of the free active substance and the risk of bleeding.
  2. Enzyme inhibition: Drugs such as cimetidine, macrolides, and azole antifungals inhibit CYP3A4/3A5 isoenzymes, slowing down warfarin metabolism.
  3. Enzyme induction: Rifampicin and phenobarbital accelerate metabolism, reducing the therapeutic effect.
Test your knowledge on the topicTasks from the «Pharmacology» course bank — instant answers and explanations.

Clinical significance

The primary risk of taking warfarin is the development of major bleeding due to a critical decrease in blood coagulation. The physician must account for dietary factors (e.g., cruciferous vegetables can affect enzyme activity) and concomitant therapy that can alter the pharmacokinetics of the drug.

Prescription details

The drug is prescribed orally in doses of 0.001–0.01 g. During dose adjustment, monitoring coagulation parameters and accounting for the patient's genetic status regarding the CYP2C9 isoenzyme are critical.

Briefly: answers to topical questions

What laboratory parameters are monitored during warfarin dose titration?

During warfarin dose titration, prothrombin time (PT) and the international normalized ratio (INR) are monitored. PT and INR assess the extrinsic pathway of blood coagulation and are used to monitor warfarin therapy. Monitoring INR is mandatory during warfarin therapy. With HAS-BLED scores ≥ 3, careful laboratory, clinical, and instrumental monitoring is required due to the high risk of bleeding.

What is the exact mechanism of vitamin K's effect on the action of indirect anticoagulants?

The mechanism of interaction is that indirect anticoagulants block the enzymes that reduce inactive vitamin K, depleting its active form reserves. Normally, the vitamin K cycle includes:

  • Hydroquinone — the active form, acting as a coenzyme in the $\gamma$-carboxylation reaction of coagulation factors (II, VII, IX, X).
  • Epoxide — the inactive form produced during the carboxylation process.

Anticoagulants inhibit vitamin K epoxide reductase and DT-diaphorase. This prevents the conversion of the epoxide back into hydroquinone. As a result, the synthesis of functional coagulation factors capable of binding calcium is impaired.

How to memorize

Warfarin — «War» (boils/thins the blood), but «Far» (pharmacokinetics) depends on CYP2C9: if the enzyme is «dormant» (polymorphism), the dose becomes toxic.

Class and exam questions

Why are sulfonamides dangerous when taking warfarin?

Sulfonamides displace warfarin from plasma protein binding, which sharply increases the concentration of free, active anticoagulant and leads to a risk of bleeding.

Which cytochrome P-450 isoenzyme is most important for the metabolism of the warfarin S-isomer?

The CYP2C9 isoenzyme. Its genetic polymorphism determines the patient's individual sensitivity to the drug.

What happens during the induction of hepatic microsomal enzymes while taking warfarin?

The metabolism and inactivation of warfarin are accelerated, leading to a decrease in its anticoagulant effect.

Something unclear? Ask the AIThe AI tutor has reviewed the material on «Warfarin» and will explain it in simple terms.

What else to study on this topic

  • The influence of CYP2C9 genetic polymorphism on dosing.
  • Comparative characteristics of direct and indirect anticoagulants.
  • The role of vitamin K in the mechanism of action of coumarin derivatives.
  • Patient management tactics in case of anticoagulant overdose.
  • Warfarin interaction with food products (grapefruit juice, vitamin K-rich foods).

Master the entire topic in the «Pharmacology» course

This is a summary. The course covers everything tested in classes and exams.

  • Complete study guide on «Warfarin» and 5,304 more pages of the subject
  • Assignments and quizzes after every topic — just like in a colloquium
  • AI tutor answers questions on the topic anytime
  • 116 video lessons on the subject

Other topics in the «Drugs and Prescriptions» section

The entire "Drugs and Prescription" section

Free video lessons: pharmacologyShort lessons with study notes — no registration required.

Watch lessons

Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.